ASPN (Aspen Aerogels) YoY EBITDA Growth: -3,100.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASPN Aspen Aerogels Inc ASPN
66 GF Score
Price $5.18
GF Value $5.01
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Aspen Aerogels YoY EBITDA Growth?

Aspen Aerogels ASPN +1.37% 66 YoY EBITDA Growth is -3,100.00% as of Jun. 2026. GuruFocus rates ASPN with a GF Score™ of 66/100 and a GF Value™ of $5.01 (Fairly Valued). The stock has 5 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Aspen Aerogels's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was -3,100.00%.

Aspen Aerogels's EBITDA per Share for the three months ended in Jun. 2026 was $-0.24.

Aspen Aerogels YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Aspen Aerogels's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aspen Aerogels YoY EBITDA Growth Chart

Aspen Aerogels Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -109.05 -92.90 79.17 270.44 -752.19

Aspen Aerogels Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -97.63 151.61 -312.50 92.96 -3,100.00
ASPN
66GF Score
Aspen Aerogels Inc ASPN
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aspen Aerogels YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Aspen Aerogels's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(-4.024-0.617)/ | 0.617 |
=-752.19 %

Aspen Aerogels's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(-0.24-0.008)/ | 0.008 |
=-3,100.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of -3,100.00% mean?
Aspen Aerogels (ASPN) has a YoY EBITDA Growth of -3,100.00% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Aspen Aerogels and its competitors.
Is Aspen Aerogels' YoY EBITDA Growth too high?
Aspen Aerogels' current YoY EBITDA Growth is -3,100.00%. Overall, Aspen Aerogels has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Aspen Aerogels' YoY EBITDA Growth compare to AIRJ and PPIH?
Aspen Aerogels' YoY EBITDA Growth of -3,100.00% can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Chemicals company?
A good YoY EBITDA Growth depends on the Chemicals industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Aspen Aerogels and its competitors. Aspen Aerogels's current YoY EBITDA Growth is -3,100.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aspen Aerogels stock overvalued right now?
Based on GuruFocus' analysis, Aspen Aerogels (ASPN) is currently considered Fairly Valued. The stock's GF Value™ is $5.01, compared to a current price of $5.18 — trading 3.4% above its estimated fair value. The current YoY EBITDA Growth is -3,100.00%. Aspen Aerogels' overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Aspen Aerogels (ASPN), the current YoY EBITDA Growth is -3,100.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aspen Aerogels (ASPN) Overvalued in 2026?

Based on GuruFocus' analysis, Aspen Aerogels stock appears to be overvalued. The current stock price of $5.18 is trading 3.4% above its estimated GF Value™ of $5.01. GuruFocus considers Aspen Aerogels to be Fairly Valued.

Key valuation signals for ASPN:

  • YoY EBITDA Growth: -3,100.00%
  • GF Value™: $5.01 vs. price of $5.18 (3.4% above fair value)
  • GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the ASPN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aspen Aerogels Business Description

Address 30 Forbes Road, Building B, Northborough, MA, USA, 01532
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology, supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Thermal Barrier segment and the United States market. Some of its products include Pyrogel XTE, Cryogel Z, Spaceloft Subsea, and others.
66GF Score

Get the complete analysis for ASPN

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.18
Price
$5.01
GF Value